Yong Yu - 13 Sep 2023 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
VP, Clinical Trial Operations
Signature
/s/ Thomas Zindrick, J.D., Attorney-in-Fact
Issuer symbol
GNLX
Transactions as of
13 Sep 2023
Net transactions value
-$629,927
Form type
4
Filing time
15 Sep 2023, 20:06:13 UTC
Previous filing
12 Sep 2023
Next filing
18 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GNLX Common Stock Sale $629,927 -29,800 -22% $21.14 106,135 13 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $21.1385, and the range of prices were between $21.00 and $21.58. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.